Long-term anticholinergic add-on therapy in overactive bladder (OAB) patients refractory to mirabegron monotherapy: a multicentre, randomized study (MILAI II study)

Research Type

Clinical

Abstract Category

Overactive Bladder

Watch this session

Links
	Abstract 9
	Lower Urinary Tract and Therapeutics Scientific Podium Short Oral Session 2
	Wednesday 13th September 2017
	09:15 - 09:22
	Cavaniglia B
	Overactive Bladder Incontinence Urgency/Frequency
	1. Division of Bioengineering and LUTD Research, Nihon University, School of Engineering, Koriyama, Japan, 2. Department of Urology, Asahikawa Medical University, Asahikawa, Japan, 3. Department of Urology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan, 4. Department of Continence Medicine, The University of Tokyo Graduate School of Medicine, Tokyo, Japan, 5. Department of Urology, Division of Clinical Medicine, Graduate Faculty of Interdisciplinary Research, University of Yamanashi, Chuo, Japan, 6. Department of Urology, North Alps Medical Center Azumi Hospital, Kitaazumi, Japan, 7. Department of Urology, Nagoya University Graduate School of Medicine, Nagoya, Japan, 8. Department of Urology, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan, 9. Department of Urology, University of Fukui Faculty of Medical Sciences, Fukui, Japan, 10. Department of Urology, Kyushu Central Hospital of the Mutual Aid Association of Public School Teachers, Fukuoka, Japan, 11. Astellas Pharma Inc, Tokyo, Japan
Presenter
O Osamu Yamaguchi
Abstract PDF Edit Abstract Abstract Centre